Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $3.64 million. The enterprise value is $176,521.
Important Dates
The next estimated earnings date is Wednesday, January 21, 2026, after market close.
| Earnings Date | Jan 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 1.50 million shares outstanding. The number of shares has increased by 117.96% in one year.
| Current Share Class | 1.50M |
| Shares Outstanding | 1.50M |
| Shares Change (YoY) | +117.96% |
| Shares Change (QoQ) | +6.09% |
| Owned by Insiders (%) | 15.71% |
| Owned by Institutions (%) | 0.47% |
| Float | 1.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.31 |
| P/TBV Ratio | 3.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.32 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -183.70 |
Financial Efficiency
Return on equity (ROE) is -178.64% and return on invested capital (ROIC) is -156.58%.
| Return on Equity (ROE) | -178.64% |
| Return on Assets (ROA) | -59.68% |
| Return on Invested Capital (ROIC) | -156.58% |
| Return on Capital Employed (ROCE) | -543.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $165,371 in taxes.
| Income Tax | 165,371 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.94% in the last 52 weeks. The beta is -1.19, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.19 |
| 52-Week Price Change | -94.94% |
| 50-Day Moving Average | 18.26 |
| 200-Day Moving Average | 34.61 |
| Relative Strength Index (RSI) | 16.71 |
| Average Volume (20 Days) | 516,227 |
Short Selling Information
The latest short interest is 280,860, so 18.73% of the outstanding shares have been sold short.
| Short Interest | 280,860 |
| Short Previous Month | 2.85M |
| Short % of Shares Out | 18.73% |
| Short % of Float | 25.20% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.80M |
| Pretax Income | -3.89M |
| Net Income | -4.05M |
| EBITDA | -5.79M |
| EBIT | -5.80M |
| Earnings Per Share (EPS) | -$34.24 |
Full Income StatementBalance Sheet
The company has $3.50 million in cash and $28,439 in debt, giving a net cash position of $3.47 million or $2.31 per share.
| Cash & Cash Equivalents | 3.50M |
| Total Debt | 28,439 |
| Net Cash | 3.47M |
| Net Cash Per Share | $2.31 |
| Equity (Book Value) | 1.07M |
| Book Value Per Share | 7.92 |
| Working Capital | 918,215 |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.53M |
| FCF Per Share | -$3.02 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
